Pancreatic cancer is relatively uncommon, with a lifetime risk of ~1.5% for individuals in the United States. For the majority of pancreatic cancers, the cause is unknown and there is no known family history of the disease. In these circumstances, a cancer is...
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk...
When I began seeing patients for cancer genetic counseling and testing back in the mid 1990s, one of the greatest fears our patients expressed was that genetic testing could tank their insurability. Frankly, genetic counselors shared this fear. We were entering...
Over the past six months, I’ve taken some of the most popular consumer DNA tests on the market so that I, as a genetic counselor, can better understand the consumer experience. I took an ancestry test a few months ago and was impressed with the accuracy of my...
